Search

After a nasoseptal flap (NSF) is performed for skull base reconstruction, patients often have significant crusting along the exposed anterior cartilaginous septum and delayed remucosalization. Placing a free mucosal graft (FMG) on the NSF donor site cartilage can help improve postoperative sinonasal symptoms. In this video, we demonstrate the use of a septal stapler to secure a septal FMG to the NSF donor site following endoscopic endonasal resection of a pituitary adenoma.By Jessa E. Miller; Jakob L. Fischer and Marilene B. WangReported by Author; Author; Author [Extracted from the article]

This article discusses the use of different techniques for skull base reconstruction in endoscopic pituitary surgery and their association with cerebrospinal fluid (CSF) leaks. The Hadad-Bassagasteguy nasoseptal flap (NSF) has been effective in reducing CSF leaks, but there is limited data on the appearance of different reconstruction techniques on MRI and their relationship to CSF leak rates. The study reviewed patient data and imaging to compare the vascularization patterns of free mucosal grafts (FMG) and NSF, and found that patients with NSF reconstruction had higher rates of intraoperative CSF leaks. However, there was no association between patterns of flap enhancement on MRI and CSF leaks. FMGs showed a predictable change in enhancement pattern over 3 months, while NSFs without flap enhancement at 1 week still demonstrated neovascularization without increased risk of complications. [Extracted from the article]

Internal maxillary artery (IMA) pseudoaneurysms are rare, and typically occur following trauma or orthognathic surgery. Pseudoaneurysms are life-threatening conditions, and expeditious workup and treatment is critical. Endoscopic treatment of an IMA pseudoaneurysm is a feasible option and should be considered when IR embolization is not available. The objective of this study is to review the literature on IMA pseudoaneurysms and present the first reported case of an IMA pseudoaneurysm successfully treated endoscopically. [ABSTRACT FROM AUTHOR]

Keywords: computed tomography; cystic fibrosis; modulator; quality of life; sinusitis EN computed tomography cystic fibrosis modulator quality of life sinusitis 1435 1438 4 11/15/22 20221101 NES 221101 INTRODUCTION The highly effective cystic fibrosis transmembrane conductance regulator modulator therapy (HEMT) with elexacaftor/tezacaftor/ivacaftor (ETI) improves pulmonary disease and chronic rhinosinusitis (CRS) in people with cystic fibrosis (PwCF).1,2 Adequately managing the sinonasal manifestations of CF is critical for maximizing quality of life (QOL) and optimizing pulmonary status.3 CRS severity can be quantified by patient-reported, radiographic, and endoscopic methods, with patient-reported and objective measures thought to represent different constructs of disease. Computed tomography, cystic fibrosis, quality of life, sinusitis, modulator Objective and patient-based measures of chronic rhinosinusitis in people with cystic fibrosis treated with highly effective modulator therapy. [Extracted from the article]